By contrast, de novo AML with KMT2A::AFF1 fusion is rare, due primarily to the very strong propensity of KMT2A::AFF1 to induce B cell precursor ALL rather than AML6,8. The gene discussed is KMT2A; the disease is acute myeloid leukemia.